Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports

July 16 : French software maker Dassault Systemes is in talks to buy drug-trial software maker ArisGlobal from Nordic Capital for about $2 billion, the Financial Times reported on Thursday, citing people familiar with the matter.• The potential deal would extend Dassault Systemes' foray into software used in life sciences and would rank as its second-biggest acquisition after its $5.8 billion takeover of clinical trial software group Medidata Solutions in 2019, the report said.• A transaction between the two firms is not a foregone conclusion, and talks could still fall apart, FT said.• Reuters could not immediately verify the report. • In April, Dassault Systemes reported first-quarter revenue of 1.51 billion euros ($1.77 billion), in line with estimates.• Hit by a prolonged slowdown in t